| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |